logo
The AJT Report
Immunotherapy for Invasive Fungal Infections in Transplant Patients
Posttransplant Prophylaxis Strategies for Hepatitis B
The Sleeping Giant Awakens—Liver Transplantation in China
The Anti-LFA-1 Trial in Islet Transplantation
Immunosuppressive Agents and CMV Risk in the VICTOR Study
Alloimmune Activation Enhances Innate Tissue Inflammation/Injury in a Mouse Model of Liver Ischemia/Reperfusion Injury
Allografts Stimulate Cross-Reactive Virus-Specific Memory CD8 T Cells with Private Specificity
Differential Role of Naïve and Memory CD4+ T-Cell Subsets in Primary Alloresponses
Regulatory T Cells Are Critical to Tolerance Induction in Presensitized Mouse Transplant Recipients Through Targeting Memory T Cells
Rapamycin-Conditioned Donor Dendritic Cells Differentiate CD4+CD25+Foxp3+ T Cells In Vitro with TGF-β1 for Islet Transplantation
The Jak Inhibitor CP-690,550 Preserves the Function of CD4+CD25brightFoxP3+ Regulatory T Cells and Inhibits Effector T Cells
Exogenous Interferon-γ Immunotherapy for Invasive Fungal Infections in Kidney Transplant Patients
De novo Thrombotic Microangiopathy in Renal Allograft Biopsies—Role of Antibody-Mediated Rejection
NK Cell Transcripts and NK Cells in Kidney Biopsies from Patients with Donor-Specific Antibodies
Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation
Clinical Outcomes for Saudi and Egyptian Patients Receiving Deceased Donor Liver Transplantation in China
Operative Start Times and Complications After Liver Transplantation
Prospective Evaluation of Intraoperative Hemodynamics in Liver Transplantation with Whole, Partial and DCD Grafts
Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low-Dose Hepatitis B Immunoglobulin
Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab
Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients
Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ
Solid Organ Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Expanding the Criteria of Organ Procurement from Donors with Prostate Cancer
Neighborhood Poverty, Racial Composition and Renal Transplant Waitlist
Induction of Indoleamine 2,3-Dioxygenase by Gene Delivery in Allogeneic Islets Prolongs Allograft Survival
Fumagillin for Treatment of Intestinal Microsporidiosis in Renal Transplant Recipients
Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Renal Artery Thrombosis After Kidney Transplantation
Long-Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease
An Innovative Sphincter Preserving Pull-Through Technique with En Bloc Colon and Small Bowel Transplantation
A Pitfall in the Current Kidney Allocation Process Using Calculated PRA(CPRA) in Patients Undergoing Desensitization
Reply to ‘A Pitfall in the Current Kidney Allocation Process Using Calculated PRA (CPRA) in Patients Undergoing Desensitization’
Is Rituximab Safe to Use in Kidney Transplant Patients?
Infection After Rituximab Therapy in Kidney-Transplant Patients
Long-Term Outcomes After Living-Donor Liver Transplantation for Alagille Syndrome